| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.70B | +18.7% |
| Cost of Revenue | $320.2M | +20.2% |
| Gross Profit | $1.38B | +18.4% |
| R&D Expense | $384.6M | +26.2% |
| SG&A Expense | $195.3M | +12.0% |
| Operating Income | $179.4M | +39.7% |
| Interest Expense | $1.0M | -28.6% |
| Pre-tax Income | $223.4M | +44.2% |
| Income Tax | -$260.3M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.02B | +30.6% |
| Short-term Investments | $96.2M | +66.2% |
| Accounts Receivable | $624.4M | +3.6% |
| Current Assets | $1.93B | +20.3% |
| Total Assets | $4.14B | +21.4% |
| Current Liabilities | $1.38B | +9.8% |
| Total Liabilities | $1.52B | +8.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $459.4M | +21.5% |
| Capital Expenditures | $26.1M | -1.3% |
| Investing Cash Flow | -$69.3M | +64.1% |
| Financing Cash Flow | -$151.6M | -399.3% |
| Free Cash Flow | $433.3M | +23.2% |
| — |
| Net Income | $483.7M | +212.8% |
| EPS (Basic) | $1.62 | +205.7% |
| EPS (Diluted) | $1.59 | +205.8% |
| Stockholders' Equity |
| $2.62B |
| +30.1% |